• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿曼苏丹国疫苗可预防疾病国家疫苗监管和监测委员会:循证方法和共识决策。

The National Committee for Vaccines Regulation and Surveillance of Vaccine-Preventable Diseases in the Sultanate of Oman: evidence-based approach and consensus decision-making.

机构信息

Department of Communicable Disease Surveillance and Control, Ministry of Health, PO Box 393, PC 100, Al Khuwair, Oman.

出版信息

Vaccine. 2010 Apr 19;28 Suppl 1:A39-41. doi: 10.1016/j.vaccine.2010.02.031.

DOI:10.1016/j.vaccine.2010.02.031
PMID:20412995
Abstract

The National Committee for Vaccines Regulation and Surveillance of Vaccine-Preventable Diseases serves as the National Immunization Technical Advisory Group (NITAG) in the Sultanate of Oman. It is the only advisory body to assist the Government in establishing policies and strategies and in evaluating new vaccines with respect to technology, quality and safety. It has six to eight core members as well ex officio members. Committee members are appointed for a period of 3 years by the Minister of Health and committee members declare their potential conflicts of interests and sign a confidentiality agreement. The cost of vaccines and the overall immunization program are considered when the committee makes its recommendations. Evidence-based decision-making could be facilitated by introducing more economic expertise to the committee.

摘要

阿曼苏丹国的国家疫苗监管和预防疾病监测委员会是国家免疫技术咨询小组(NITAG)。该委员会是唯一协助政府制定政策和战略以及评估新技术、质量和安全性疫苗的咨询机构。该委员会有六到八名核心成员和当然成员。委员会成员由卫生部长任命,任期三年,成员须声明其潜在的利益冲突,并签署保密协议。委员会在提出建议时会考虑疫苗成本和整个免疫计划。通过向委员会引入更多的经济专业知识,可以促进基于证据的决策。

相似文献

1
The National Committee for Vaccines Regulation and Surveillance of Vaccine-Preventable Diseases in the Sultanate of Oman: evidence-based approach and consensus decision-making.阿曼苏丹国疫苗可预防疾病国家疫苗监管和监测委员会:循证方法和共识决策。
Vaccine. 2010 Apr 19;28 Suppl 1:A39-41. doi: 10.1016/j.vaccine.2010.02.031.
2
The structure, role, and procedures of the U.S. Advisory Committee on Immunization Practices (ACIP).美国免疫实践咨询委员会(ACIP)的结构、作用和程序。
Vaccine. 2010 Apr 19;28 Suppl 1:A68-75. doi: 10.1016/j.vaccine.2010.02.037.
3
The French Technical Vaccination Committee (CTV).法国技术疫苗接种委员会(CTV)。
Vaccine. 2010 Apr 19;28 Suppl 1:A42-7. doi: 10.1016/j.vaccine.2010.02.032.
4
Canada's National Advisory Committee on Immunization (NACI): evidence-based decision-making on vaccines and immunization.加拿大免疫咨询委员会(NACI):疫苗和免疫接种的循证决策。
Vaccine. 2010 Apr 19;28 Suppl 1:A58-63. doi: 10.1016/j.vaccine.2010.02.035.
5
Immunization policy development in Thailand: the role of the Advisory Committee on Immunization Practice.泰国免疫政策的制定:免疫实践咨询委员会的作用。
Vaccine. 2010 Apr 19;28 Suppl 1:A104-9. doi: 10.1016/j.vaccine.2010.02.043.
6
Role of National Immunization Technical Advisory Group on improvement of immunization programmes in the Islamic Republic of Iran.伊朗伊斯兰共和国国家免疫技术咨询小组在改善免疫规划方面的作用。
Vaccine. 2010 Apr 19;28 Suppl 1:A35-8. doi: 10.1016/j.vaccine.2010.02.030.
7
Informing decision makers: experience and process of 15 National Immunization Technical Advisory Groups.为决策者提供信息:15 个国家免疫技术咨询专家组的经验和过程。
Vaccine. 2010 Apr 19;28 Suppl 1:A1-5. doi: 10.1016/j.vaccine.2010.02.025.
8
The Federal Vaccination Commission in Switzerland: an officially appointed independent commission ensuring evidence-based recommendations and transparent procedures.瑞士联邦疫苗接种委员会:一个经官方任命的独立委员会,确保提供基于证据的建议和透明的程序。
Vaccine. 2010 Apr 19;28 Suppl 1:A48-53. doi: 10.1016/j.vaccine.2010.02.033.
9
Strengthening vaccination policies in Latin America: an evidence-based approach.加强拉丁美洲的疫苗接种政策:循证方法。
Vaccine. 2013 Aug 20;31(37):3826-33. doi: 10.1016/j.vaccine.2012.12.062. Epub 2013 Jan 25.
10
Participatory decision-making through the Advisory Committee on Communicable Diseases: the Sri Lankan experience.通过传染病咨询委员会进行参与式决策:斯里兰卡的经验。
Vaccine. 2010 Apr 19;28 Suppl 1:A96-103. doi: 10.1016/j.vaccine.2010.02.042.

引用本文的文献

1
Barriers to the HPV vaccination program in the Eastern Mediterranean region: a narrative review.东地中海区域人乳头瘤病毒疫苗接种计划的障碍:叙述性综述
J Turk Ger Gynecol Assoc. 2023 Mar 15;24(1):48-56. doi: 10.4274/jtgga.galenos.2022.2022-6-6. Epub 2022 Dec 30.
2
Priority setting of vaccine introduction in Bangladesh: a multicriteria decision analysis study.孟加拉国疫苗引入的优先事项设定:一项多准则决策分析研究。
BMJ Open. 2022 Feb 28;12(2):e054219. doi: 10.1136/bmjopen-2021-054219.